482 related articles for article (PubMed ID: 26203745)
21. A New Ophthalmic Pharmaceutical Formulation, Topical Sulglycotide, Enhances the Ocular Mucin Secretion in Desiccation Stress-Mediated Dry Eye Disease.
Lee H; Jeon S; Kim CE; Park YJ; Yang J
Invest Ophthalmol Vis Sci; 2019 Mar; 60(4):1076-1087. PubMed ID: 30901389
[TBL] [Abstract][Full Text] [Related]
22. Improvement of corneal barrier function by the P2Y(2) agonist INS365 in a rat dry eye model.
Fujihara T; Murakami T; Fujita H; Nakamura M; Nakata K
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):96-100. PubMed ID: 11133853
[TBL] [Abstract][Full Text] [Related]
23. RGN-259 (thymosin β4) improves clinically important dry eye efficacies in comparison with prescription drugs in a dry eye model.
Kim CE; Kleinman HK; Sosne G; Ousler GW; Kim K; Kang S; Yang J
Sci Rep; 2018 Jul; 8(1):10500. PubMed ID: 30002412
[TBL] [Abstract][Full Text] [Related]
24. Effect of Topical 5-Aminoimidazole-4-carboxamide-1-β-d-Ribofuranoside in a Mouse Model of Experimental Dry Eye.
Sung MS; Li Z; Cui L; Choi JS; Choi W; Park MJ; Park SH; Yoon KC
Invest Ophthalmol Vis Sci; 2015 May; 56(5):3149-58. PubMed ID: 26024098
[TBL] [Abstract][Full Text] [Related]
25. Trehalose protects against ocular surface disorders in experimental murine dry eye through suppression of apoptosis.
Chen W; Zhang X; Liu M; Zhang J; Ye Y; Lin Y; Luyckx J; Qu J
Exp Eye Res; 2009 Sep; 89(3):311-8. PubMed ID: 19345212
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic effects of epidermal growth factor on benzalkonium chloride-induced dry eye in a mouse model.
Xiao X; He H; Lin Z; Luo P; He H; Zhou T; Zhou Y; Liu Z
Invest Ophthalmol Vis Sci; 2012 Jan; 53(1):191-7. PubMed ID: 22159022
[TBL] [Abstract][Full Text] [Related]
27. A murine model of dry eye induced by topical administration of erlotinib eye drops.
Yang QC; Bao J; Li C; Tan G; Wu AH; Ye L; Ye LH; Zhou Q; Shao Y
Int J Mol Med; 2018 Mar; 41(3):1427-1436. PubMed ID: 29286080
[TBL] [Abstract][Full Text] [Related]
28. Preservation of tear film integrity and inhibition of corneal injury by dexamethasone in a rabbit model of lacrimal gland inflammation-induced dry eye.
Nagelhout TJ; Gamache DA; Roberts L; Brady MT; Yanni JM
J Ocul Pharmacol Ther; 2005 Apr; 21(2):139-48. PubMed ID: 15857280
[TBL] [Abstract][Full Text] [Related]
29. Effects of topical cyclosporine a plus artificial tears versus artificial tears treatment on conjunctival goblet cell density in dysfunctional tear syndrome.
Demiryay E; Yaylali V; Cetin EN; Yildirim C
Eye Contact Lens; 2011 Sep; 37(5):312-5. PubMed ID: 21792057
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic Efficacy of Nanocomplex of Poly(Ethylene Glycol) and Catechin for Dry Eye Disease in a Mouse Model.
Lee H; Shim W; Kim CE; Choi SY; Lee H; Yang J
Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1682-1691. PubMed ID: 28319642
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic efficacy of trehalose eye drops for treatment of murine dry eye induced by an intelligently controlled environmental system.
Li J; Roubeix C; Wang Y; Shi S; Liu G; Baudouin C; Chen W
Mol Vis; 2012; 18():317-29. PubMed ID: 22355243
[TBL] [Abstract][Full Text] [Related]
32. Topical apolipoprotein A-1 may have a beneficial effect on the corneal epithelium in a mouse model of dry eye: a pilot study.
Nyunt AK; Ishida Y; Yu Y; Shimada S
Eye Contact Lens; 2008 Sep; 34(5):287-92. PubMed ID: 18779669
[TBL] [Abstract][Full Text] [Related]
33. Effect of chitosan-N-acetylcysteine conjugate in a mouse model of botulinum toxin B-induced dry eye.
Hongyok T; Chae JJ; Shin YJ; Na D; Li L; Chuck RS
Arch Ophthalmol; 2009 Apr; 127(4):525-32. PubMed ID: 19365035
[TBL] [Abstract][Full Text] [Related]
34. The leaves of Diospyros kaki exert beneficial effects on a benzalkonium chloride-induced murine dry eye model.
Kim KA; Hyun LC; Jung SH; Yang SJ
Mol Vis; 2016; 22():284-93. PubMed ID: 27110091
[TBL] [Abstract][Full Text] [Related]
35. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease.
Wang Y; Ogawa Y; Dogru M; Kawai M; Tatematsu Y; Uchino M; Okada N; Igarashi A; Kujira A; Fujishima H; Okamoto S; Shimazaki J; Tsubota K
Bone Marrow Transplant; 2008 Feb; 41(3):293-302. PubMed ID: 17982500
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic effects of topical doxycycline in a benzalkonium chloride-induced mouse dry eye model.
Zhang Z; Yang WZ; Zhu ZZ; Hu QQ; Chen YF; He H; Chen YX; Liu ZG
Invest Ophthalmol Vis Sci; 2014 May; 55(5):2963-74. PubMed ID: 24722696
[TBL] [Abstract][Full Text] [Related]
37. Topical steroid and non-steroidal anti-inflammatory drugs inhibit inflammatory cytokine expression on the ocular surface in the botulinum toxin B-induced murine dry eye model.
Zhu L; Zhang C; Chuck RS
Mol Vis; 2012; 18():1803-12. PubMed ID: 22815633
[TBL] [Abstract][Full Text] [Related]
38. A mouse dry eye model induced by topical administration of the air pollutant particulate matter 10.
Li J; Tan G; Ding X; Wang Y; Wu A; Yang Q; Ye L; Shao Y
Biomed Pharmacother; 2017 Dec; 96():524-534. PubMed ID: 29032336
[TBL] [Abstract][Full Text] [Related]
39. 0.005% Preservative-Free Latanoprost Induces Dry Eye-Like Ocular Surface Damage via Promotion of Inflammation in Mice.
Yang Y; Huang C; Lin X; Wu Y; Ouyang W; Tang L; Ye S; Wang Y; Li W; Zhang X; Liu Z
Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3375-3384. PubMed ID: 30025085
[TBL] [Abstract][Full Text] [Related]
40. Effects of DA-6034 on aqueous tear fluid secretion and conjunctival goblet cell proliferation.
Choi SM; Lee YG; Seo MJ; Kang KK; Ahn BO; Yoo M
J Ocul Pharmacol Ther; 2009 Jun; 25(3):209-14. PubMed ID: 19456255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
